ArticleFrontiers in pharmacology2024

Structure-based screening of FDA-approved drugs identifies potential histone deacetylase 3 repurposed inhibitor: molecular docking and molecular dynamic simulation approaches.

Anas Shamsi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.